SlimTarget Medical

Company Overview

Snapshot

Founded in January 2021, SlimTarget Medical operates with 1–10 employees. The company has secured funding across one round from Israel MedicUp. In January 2022, SlimTarget Medical received Seed funding.

Business overview

SlimTarget Medical is a Health Tech & Life Sciences company developing a focused ultrasound-based treatment for weight loss. The company's core technology applies MRI-guided focused ultrasound to ablate a specific point in the brain, aiming to reduce appetite in overweight patients with chronic conditions like diabetes and high blood pressure. This non-invasive procedure is positioned as an alternative to bariatric surgery, serving the healthcare and medical devices industries by targeting patients and medical equipment sectors.

Company Intelligence Q&A

What is SlimTarget Medical's primary focus?

SlimTarget Medical focuses on developing a focused ultrasound-based treatment for weight loss, particularly for overweight patients with chronic conditions such as diabetes and high blood pressure.

When was SlimTarget Medical founded?

SlimTarget Medical was founded in January 2021.

What technology does SlimTarget Medical utilize?

SlimTarget Medical utilizes MRI-guided focused ultrasound technology to perform precise ablations in the brain, aiming to curb appetite.

What is the intended benefit of SlimTarget Medical's treatment?

The treatment aims to provide a non-invasive, painless, and long-term effective alternative to bariatric surgery, reducing associated complications, costs, and treatment time.

Which investor participated in SlimTarget Medical's Seed round?

In January 2022, SlimTarget Medical received Seed funding from Israel MedicUp.